Overview

Part 1 - A Clinical Trial in Children and Adults With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
A Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Children and Adults with Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Phase:
Phase 2
Details
Lead Sponsor:
Aldeyra Therapeutics, Inc.